The Vanderbilt VentureStudio is the place to go for support when planning, launching, and growing your next startup company to commercialize a Vanderbilt innovation.
Support services include business model development and validation, financial modeling, proof of concept testing, company formation and governance, and investor engagement.
Vanderbilt Center for Technology Transfer and Commercialization's mission is to provide professional commercialization services to the Vanderbilt community, thus optimizing the flow of innovation to the marketplace and generating revenue that supports future research activities, while having a positive impact on society.
CTTC bridges the gap between academia and industry by moving innovative products from the lab bench to the marketplace. We accomplish this by:
CTTC is the conduit through which companies access technologies that are developed while conducting research and caring for patients at Vanderbilt. We work closely with faculty researchers to evaluate, protect, and license inventions to companies, which they then develop into new products that benefit society.
10-Year Snapshot
Benoit Dawant, Ph.D., Cornelius Vanderbilt Professor of Electrical and Computer Engineering and Director of VISE. His main research interests include medical image processing and analysis. Current projects include the development of algorithms and systems to assist in the placement of deep brain stimulators used for the treatment of Parkinson’s disease and other movement disorders, the placement of cochlear implants used to treat hearing disorders, or the creation of radiation therapy plans for the treatment of cancer. Dr. Dawant is a co-founder of two spinoff companies: Pathfinder Therapeutics, Inc. and Neurotargeting, LLC.